Objective The subsets and the polarization of lymphocytes in bone marrow from low-risk myelodysplastic syndrome (MDS) were studied and compared with those from patients with aplastic anemia (AA). Methods A total of 34 patients with low-risk MDS (IPSS score!1.0) who presented abnormal chromosomes and 16 patients with AA were enrolled in this study. We determined T lymphocyte subsets, T cells polarization status, and the percentages of NK cells and of B lymphocytes in bone marrow and compared these parameters between the two groups of patients. As controls, 24 patients with high-risk MDS (IPSS score>1.0) presenting abnormal chromosomes and 22 healthy/benign hematologic disease subjects were used. Results In low-risk MDS/AA patients, the percentage of CD3+ lymphocytes was significantly increased compared to controls (p=0.006 and p=0.001), while the percentage of CD19+ lymphocytes was significantly decreased (p<0.001 and p=0.002); there were no significant differences between MDS/AA and normal controls in other parameters; For low-risk MDS patients, the polarization status of bone marrow CD4+ cells toward Th1 (Th1/Th2) and of CD8+ cells toward Tc1 (Tc1/Tc2) was stronger than that for AA patients (p= 0.05 and p<0.001). Other parameters did not show significant differences; Regardless of the predominance of CD4 or CD8 T cells, all patients with low-risk MDS were accompanied with elevated Tc1 polarization (Tc1/ Tc2). Conclusion In both AA and MDS, the number of total T lymphocytes increased. However, polarization towards Th1 and Tc1 was obviously stronger in MDS patients than in AA patients. This might be related to T cell stimulation from the clones of malignant hematopoietic cells.
Introduction
Bone marrow failure in partial early or low-risk myelodysplastic syndrome (MDS) patients has been considered to be related to the strong immunologic function of T lymphocytes. Evidence has been proposed in support of this idea: 1) in MDS, the proportion of T lymphocytes in peripheral blood, as well as the percentage of CD4+ and CD8+ cells increased (1, 2) ; 2) the ratio of CD4/CD8 decreased (2, 3) ; 3) the polarization to Th1 or/and Tc1 strengthened (1); 4) in vitro, mononuclear cells without T lymphocytes grew and T a b l e 1 . T h e Ge n e r a l Da t a o f t h e MDS P a t i e n t s wi t h ≤ 1 . 0 o f I P S S S c o r e somes and used lymphocytes from bone marrow to investigate the prevalence of different subsets of lymphocytes and the polarization status of these cells. It has been shown that the sthenic immunologic function of T lymphocytes can induce the inhibition of hematopoiesis and bone marrow failure in AA (9) . However, it is still controversial whether CD4+ (Th1) T lymphocytes or CD8+ (Tc 1) T lymphocytes are central to this effect (10, 11) . Also, few reports exist on differences in abnormal immunological function in AA and in low-risk MDS. Although the diagnosis of AA in previous studies was based on morphology, it did not exclude patients who had both cellular morphology characteristics of AA and abnormal chromosomes (12) (13) (14) (15) . In fact, according to accepted definitions, AA should refer to bone marrow failure induced by overreaction to self-/ unclear-antigen from T lymphocytes, while MDS should refer to bone marrow failure induced by overreaction to selfmalignant clonal cells from T lymphocytes that carry tumorspecific or related antigens. In this study, all AA patients exhibited cellular morphology characteristics consistent with AA, and they had no abnormal clones as determined by G band analysis or FISH detection.
The purpose of our study was primarily to compare the distribution and polarization status of lymphocytes obtained from bone marrow in low-risk MDS and AA. Benign hematologic disease patients and healthy persons were taken as controls. At the same time, we investigated the immunological status of high-risk MDS.
Patients and Methods

Patients
A total of 34 patients with low-risk MDS (IPSS (16) score!1.0) were studied; all of them presented abnormal chromosomes according to G-banding analysis or FISH (fluorescence in situ hybridization). General data and detailed WHO (17) classification are shown in Table 1 ; 16 patients with AA, including 5 cases with pure red cell aplastic anemia (PRCA), were enrolled. Nine of these presented normal chromosomes when analyzed by G-banding; the others failed to achieve results by G-banding but showed normal karyotypes when checked by FISH using a probe for 5q-/20 q-/ -7/+8/-y. 22 samples, including 17 healthy donors and 5 cases with nutritional anemia including iron deficiency anemia and megaloblast anemia, were taken as normal controls. 17 patients with high-risk MDS with >1.0 IPSS score were also studied to observe the disparity of lymphocytic immunity when the diseases were diagnosed as advanced. To make the results comparable with those for low-risk MDS patients, all of these also possessed abnormal chromosomes (seen in Table 2 ). This study was approved by the Ethics Committee of the sixth hospital affiliated to Shanghai Jiao-Tong University, and informed consent was obtained from all tested patients and controls.
T a b l e 2 . T h e Ge n e r a l Da t a o f t h e MDS P a t i e n t s wi t h > 1 . 0 o f I P S S S c o r e
Detection of CD3, CD4, CD8, CD4/CD8, CD56 and CD 19
Flow cytometry was performed using Coulter Epics-XL (Beckman Coulter, Fullerton, CA) and analyzed by System II Software (Beckman Coulter). For each tube, 10,000 events were collected in a gate created around the viable lymphocyte population using FSC/SSC. Anti-CD8 antibody conjugated with phycoerythrin-Texas Red (ECD), anti-CD4 and anti-CD19 conjugated with fluorescein isothiocyanate (FITC), anti-CD3 conjugated with phycoerythrin-cyanin 5 (PC5), anti-CD56 conjugated with PE (Beckman Coulter) were used to label BM nucleated cells. Mixtures were incubated at room temperature (18) (19) (20) (21) (22) (23) (24) (25) for 30 minutes in the dark. Subsequently, erythrocytes were lysed using lysing solution (Beckman Coulter). The relative numbers of CD3, CD 4, CD8, CD56 and CD19-positive lymphocytes were represented through quadrant chart.
Measurement of Th and Tc subsets
Measurement of Th and Tc subsets was performed by flow cytometry determination of cytoplasmic IFN-γ and IL-4 in marrow CD4 and CD8 positive cells, respectively (18) . Briefly, bone marrow aspiration, anticoagulated by heparin lithium, was incubated with 2.5 mg/dL phorbol 12-myristate 13-acetate (PMA), 100 mg/dL ionomycin, and 10 g/dL Brefeldin A (Sigma Chemical Co., St. Louis, MO) at 37 in a humidified atmosphere with 5% CO2 for 4 hours. The cells were then stained anti-CD3 with PC5-labeled and anti-CD8 with ECD-labeled (Beckman Coulter) at room temperature for 15 minutes. After treatment with lysing solution (Intra-PreP Permeabilization reagent A, Beckman Coulter) and permeabilizing solution (IntraPreP Permeabilization reagent B, Beckman Coulter), cells were stained with FITC-labeled anti-human IFN-γ and PE-labeled anti-human IL-4 (Beck-
F i g u r e 1 . T h e CD3 + ( T -c e l l ma r k e r ) ，CD5 6 ( NK-c e l l ma r k e r ) a n d CD1 9 ( B -c e l l ma r k e r ) l y mp h oc y t e r a t i o i n l o w-r i s k MDS ，h i g h -r i s k MDS ，AA p a t i e n t s a n d n o r ma l c o n t r o l s we r e p r e s e n t i n t h e d o t p l o t ; CD3 + l y mp h o c y t e r a t i o i n b o t h l o w-r i s k MDS a n d AA s h o we d s i g n i f i c a n t i n c r e a s e s r e l at i v e t o t h a t o f n o r ma l c o n t r o l s ( p = 0 . 0 0 6 a n d p = 0 . 0 0 1 , r e s p e c t i v e l y ) ; h o we v e r , CD1 9 + B l y mp h oc y t e s we r e mu c h l e s s p r e v a l e n t i n t h e MDS / AA g r o u p c o mp a r e d t o c o n t r o l s ( p < 0 . 0 0 1 a n d p = 0 . 0 0 2 , r e s p e c t i v e l y ) ; T h e p e r c e n t a g e s o f CD4 + T ，CD8 + T l y mp h o c y t e s a n d t h e CD4 / CD8 r a t i o i n MDS s h o we d n o s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e s f r o m t h o s e o f AA a n d n o r ma l c o n t r o l .
man Coulter) at room temperature for 15 minutes. For each tube, 10,000 events were collected in a gate created around the viable lymphocyte population. A second gate was then created around the CD3+ cells. Dot plots of CD8 versus type I and type II cytokines were created. Then, the percentages of CD8+ and CD8-cytokine-producing cells in the total CD3+ cell population were calculated. Th and Tc subsets were defined as Th1 (CD8-/INF-γ+), Th2 (CD8-/IL-4+), Tc1 (CD8+ /INF-γ+), Tc2 (CD8+/IL-4+). The ratio of Th1/Th2 and Tc1/Tc2 cells was calculated. Quadrants were applied to the isotype control dot plots and medium-control dot plots to exclude nonspecific staining of cells.
Statistical analysis
Results are expressed as mean±SD. Comparisons between two samples populations were analyzed by Student's t test. All statistical analyses were performed using the SPSS 11.5 System.
Results
All results on bone marrow lymphocyte subsets and polarization status of cells in experimental and control groups are presented in Fig. 1, 2. 1. Comparison between low-risk MDS/AA and controls: The CD3+lymphocyte ratio in both low-risk MDS and AA showed significant increases relative to that of normal controls (p=0.006 and p=0.001, respectively). At the same time, CD19+ B lymphocytes were much less prevalent in the MDS/AA group compared to controls (p<0.001 and p= 0.002, respectively). The other parameters showed no statistically significant differences from those of controls (Fig. 1) . In addition, the low-risk MDS patients showed a significant increase in Th1 polarization (Th1/Th2) and Tc1 polarization (Tc1/Tc2) compared to controls (p=0.004 and p=0.011, respectively), but the AA patients did not show a significant increase compared to controls (Fig. 2) .
Comparison between low-risk MDS and AA:
compared to AA, low-risk MDS with!1.0 IPSS score exhibited stronger polarization in CD4+ subset towards Th1 polarization (p=0.05) and in CD8+ subset towards Tc1 polarization (p<0.001) (Fig. 2) . None of the other parameters showed statistical differences between these two groups.
Characteristic analysis of immunological parameters in low-risk MDS:
Of 34 low-risk MDS patients, 6 showed increased CD4+ T cells (exceeding the normal upper limit 0 . 0 0 4 a n d p = 0 . 0 1 1 , r 
F i g u r e 2 . T h e l o w-r i s k MDS p a t i e n t s s h o we d s i g n i f i c a n t i n c r e a s e i n T h 1 p o l a r i z a t i o n ( T h 1 / T h 2 ) a n d T c 1 p o l a r i z a t i o n ( T h 1 / T h 2 ) c o mp a r e d t o c o n t r o l s ( p =
e s p e c t i v e l y ) , b u t t h e AA p a t i e n t s d i d n o t s i g n i f i c a n t i n c r e a s e c o mp a r e d t o c o n t r o l s ( p < 0 . 0 5 a n d p < 0 . 0 5 , r e s p e c t i v e l y ) ; c o mp a r e d t o AA，l o w-r i s k MDS wi t h ≤ 1 . 0 I P S S s c o r e e x h i b i t e d s t r o n g e r p o l a r i z a t i o n i n CD4 + s u bs e t t o wa r d s T h 1 p o l a r i z a t i o n ( p = 0 . 0 5 ) a n d i n CD8 + s u b s e t t o wa r d s T c 1 p o l a r i z a t i o n ( p < 0 . 0 0 1 ) .
of our laboratory). In these samples, the average ratio of Tc1/Tc2 was 112.6. A total of 20 of the 34 patients presented elevated CD8+ T cells, with an average Tc1/Tc2 of 83. The remaining eight patients possessed basically normal numbers of CD4+ and CD8+ T cells. Nevertheless, the average Tc1/Tc2 in these patients reached 106.4. Regardless of the predominance of CD4 or CD8 T cells, all patients with low-risk MDS were accompanied with elevated Tc1 polarization (Tc1/Tc2). In addition, almost all low-risk MDS presented obviously decrease in CD19+ B cells according to the normal lower limit of our laboratory.
Comparison between high risk and low risk MDS:
Compared with low-risk MDS, the percentage of total T lymphocytes (CD3+) and CD4+ T lymphocytes, as well as the CD4/CD8 ratio, showed a certain extent decrease in high-risk MDS (close to normal controls) (Fig. 1) . The polarization towards Th1 and Tc1 also presented a downward trend, although no significant difference compared to low risk MDS was found.
Discussion
It is widely accepted that most AA patients exhibit sthenic function of T lymphocytes. There is evidence that non-progressive (low-risk) MDS patients also present sthenic function of T lymphocytes (see introduction). In the present study, it was observed that the total T lymphocyte (CD3+) proportion among all lymphocytes increased in both AA and low-risk MDS (IPSS score!0.5). The statistical significance of these results indicates that AA and low-risk MDS are, indeed, both associated with an increase in T lymphocytes and supports the view that T lymphocytes are related to the mechanisms of these two bone marrow failure diseases. At the same time, the proportion of CD19+ B lymphocytes in AA and low-risk MDS decreased substantially compared with normal controls. There are two possible explanations for this phenomenon. First, the relative decrease in B lymphocytes could be due to proliferation of T lymphocytes in AA and low-risk MDS. However, this explanation seems unlikely because NK cells, which are another of the three main lymphocyte subsets, did not obviously decrease either in MDS or in AA. Second, CD34+/CD19+ hemopoietic stem/ progenitor cells in bone marrow which can develop and differentiate to be lymphocytes, decreased. Under normal conditions, CD34+ cells in bone marrow include two subsets, (CD34+/CD19+) and (CD34+/CD19-). CD34+/CD19+ cells can differentiate to B lymphocytes. It has been reported that B progenitor cells (CD34+/CD19+) are decreased significantly in MDS patients and that B-related gene expression is also decreased (19, 20) . It seems likely, therefore, that reduction in (CD34+/CD19+) B lymphocyte progenitors explains the B lymphocyte decrease seen in MDS bone marrow. In AA, the amount of hemopoietic stem/progenitor cells obviously decreases early in the course of the disease, whereas the number of adult B lymphocytes is significantly decreased (21) .
It is still not clear which antigen or antigens induce the overreaction of T lymphocytes during the progression of AA. It has been proposed that the presenting antigen might be a normal antigen in the patient's body, such as kinectin or diazepam-binding related protein-1 (22, 23) . It was reported that AA can develop into MDS or AML, with concomitant appearance of malignant hemopoietic cell clones, such as monosomy 7 (24) . However, the classification of patients as AA should include only those who do not exhibit malignant hemopoietic cells. Or even so, malignant hemopoietic cell clones presenting in such patients, are likely to arise through T cell immunological function, not primarily from bone marrow, where such clonal cells would not be detectable by routine methods. In our study, although the amount of T lymphocytes in AA increased compared with normal controls, polarization of CD4+ cells to Th1 and CD 8+ cells to Tc1 was not obvious. These results support our view that the T cells in AA bone marrow were directed at self-antigen or that, if tumor-related antigens were present; these had been inhibited by self-immunological function. In the low-risk MDS patients in this study, the persistent tumor-related or tumor-specific antigens carried by malignant hemopoietic cell clones likely acted as a sufficiently strong immunogen to both stimulate the increase in T lymphocytes and induce the polarization of CD4+ cells and CD 8+ cells to Th1 and Tc1, as the immune system of these patients attempted to control the further proliferation of the malignant clones and the progress of the disease by negative cell factors and direct killing function. Interestingly, whether patients had CD4 higher than normal, CD8 higher than normal or both CD4 and CD8 within the normal range, the polarization of their CD8+ cells toward Tc1(Tc1/Tc2) was very strong. These observations further support our earlier conclusion that low-risk MDS is associated with strong cytotoxic T cell immunology directed toward malignant hemopoietic cell clones. As for what is the concrete material (as tumorous antigens) on the surface of MDS malignant cells which could stimulate the T cell immunity still is unclear, although this kind of research is ongoing in some centers (25) .
The mechanism of the progression of low-risk MDS or its transition to leukemia is still not clear. Two possibilities might be considered: 1) the invasive properties of the existing malignant cells increase or new subsets of these cells with stronger invasive properties appear; 2) the anti-tumor immunological function of the patients decreases, or, despite the fact that the T cell immunological function of MDS patients shows no obvious differences from that of normal controls, their anti-tumor immunological function fails to increase together with the proliferation of malignant clones and this leads to disease development. In our study, the comparison of high-risk MDS with low-risk MDS showed that the number of T lymphocytes (CD3+) in high-risk MDS was significantly decreased and their polarization toward Th1 and Tc1 was obviously weakened. These observations indicate that an absolute or relative decrease of anti-tumor immunologic function plays a role in the development of MDS.
